Pediatric Applications of BTK Inhibitors: Potential and Challenges
While the application of BTK inhibitors in pediatric oncology is still emerging, their potential to improve outcomes for children with hematologic cancers is promising. With continued research and clinical trials, these therapies could become a valuable addition to pediatric cancer treatme
